What you need to know about the new botulinum toxin product.
Generic Detrol LA® (tolterodine tartrate extended release capsules, Chamber® Pharmaceuticals, Inc.)
ULTOMIRIS (ravulizumab-cwvz , Alexion Pharmaceuticals, Inc.)
Indications: treatment of adult patients with paroxysmal nocturnal hemoglobinuria
ELZONRIS (tagraxofusp-erzs, Stemline® Therapeutics)
Indications: Treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in adults and in pediatric patients 2 years and older
Siklos (hydroxyurea, Medunik USA)
Indications: pediatric patients, 2 years of age and older, with sickle cell anemia with recurrent moderate to severe painful crises
Xospata (gilteritinib, Astellas)
Indications: Adult patients with relapsed or refractor acute myeloid leukemia (AML) with an FLT3 mutation.
Firdapse (amifampridine, Catalyst Pharmaceuticals)
Indications: treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults.
Vitrakvi (larotrectinib, Bayer and Loo Oncology Inc)
Indications: treatment of adult and pediatric patients with solid tumors that:
Gamifant (emapalumab-lzsg, Sobi)
Daurismo (glasdegib, Pfizer)